4 Results

People

  1. Horwitz
    Horwitz
  2. Cordeiro
    Cordeiro
  3. Dogan
    Dogan
  4. Galasso
    Galasso
  5. Ganesan
    Ganesan
  6. Ghione
    Ghione
  7. Hu
    Hu
  8. Ni
    Ni
  9. Noy
    Noy
  10. Straus
    Straus

Groups

  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Lymphoma (4)
  5. Population Sciences Research Program (2)
  6. Biostatistics Service (1)
  7. Epidemiology and Biostatistics (1)
  8. Executive Committee, Center for Hematologic Malignancies (1)
  9. Sloan Kettering Institute Postdocs (1)
  10. Surgery (1)
  1. "follow up"
  2. "Elsevier Science, Inc."
  3. "Lymphoma"
Formats
  1. Journal Article (4)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Lymphoma (4)
  5. Population Sciences Research Program (2)
  6. Biostatistics Service (1)

More Groups

People
  1. Steven Horwitz (2)
  2. Ahmet Dogan (1)
  3. Ai Ni (1)
  4. Anas Younes (1)
  5. Ariela Noy (1)
  6. David Straus (1)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (2)
Publications
  1. The Lancet Haematology (3)
  2. Journal of Plastic Reconstructive and Aesthetic Surgery (1)
Publishers
  1. Elsevier Science, Inc. (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): Phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
    Journal Article

    Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Lee, J. Y.; Rudek, M. A.; Chadburn, A.; Ratner, L.; Henry, D. H.; Cesarman, E.; DeMarco, C. E.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
    Journal Article

    Straus, D. J.; Długosz-Danecka, M.; Connors, J. M.; Alekseev, S.; Illés, Á; Picardi, M.; Lech-Maranda, E.; Feldman, T.; Smolewski, P.; Savage, K. J.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants
    Journal Article

    Cordeiro, P. G.; Ghione, P.; Ni, A.; Hu, Q.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Journal of Plastic Reconstructive and Aesthetic Surgery (2020)

    Fulltext@MSK | Save
  • Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: A prospective cohort study from the international T-cell Project
    Journal Article

    Fox, C. P.; Civallero, M.; Ko, Y. H.; Manni, M.; Skrypets, T.; Pileri, S.; Kim, S. J.; Cabrera, M. E.; Shustov, A. R.; Chiattone, C. S.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save